Add time:07/17/2019         Source:sciencedirect.com

Scropolioside A, an iridoid isolated from Scrophularia auriculata ssp. pseudoauriculata, showed anti-inflammatory properties against different experimental models of delayed-type hypersensitivity. This iridoid reduced the oedema induced by oxazolone by 79% (72 h) at 0.5 mg/ear while reducing that induced by sheep red blood cells by 47% (18 h), 45% (24 h) and 36% (48 h) at 10 mg/kg. In vivo it reduced both oedema formation and cell infiltration whereas in vitro it reduced the proliferation of activated T-lymphocytes (IC50 of 67.74 μM). Treatment with scropolioside A (100 μM) 18 and 24 h after phytohemagglutinin stimulation increased the number of cells arrested in the subG0 phase whereas treatment 3 h after stimulation clearly increased the number of cells that passed to the S phase. Scropolioside A also inhibited the production of prostaglandin E2, leukotriene B4, nitric oxide, interleukin-1β, interleukin-2, interleukin-4, tumour necrosis factor-α and interferon-γ, but had no effect on the production of interleukin-10. Moreover, it modified the expression of both nitric oxide synthase-2 and cyclooxygenase-2, as well as the activation of nuclear factor-κB in RAW 264.7 macrophages.

We also recommend Trading Suppliers and Manufacturers of scropolioside A (cas 116064-68-7). Pls Click Website Link as below: cas 116064-68-7 suppliers